Clinical Trial Update: Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining how concomitant methotrexate affects the efficacy, safety, and adherence of ustekinumab in active psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Dr. Frank Behrens | Conditions: Psoriatic Arthritis | Phase 3 | Status: COMPLETED